Centene stock: buy or sell?
July 16th, 2019
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States.
Should I buy Centene stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Centene stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Centene stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 11 ratings published for CNC stock in the last month. The general sentiment of these ratings is bullish for CNC stock, with 9 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-3-29||Credit Suisse Group||Neutral||Neutral|
|2019-2-7||Jefferies Financial Group||n/a||Buy|
Centene stock analysis
Centene shares slightly fell -0.57% to $53.75 today.
Shares of Centene ended today at $53.75 and slightly fell an ugly -0.57%.
After boosting a phenomenal 5.56% in a week last week, Centene closed this week at $53.75 and decreased an unpleasant -1.39%. Late June CNC collapsed a hair-raising -7.49% in just one week.
Observing the weekly chart, price is in a simple uptrend, tested $49.96 level and now climbing back aiming its last top at $58.24. Far behind is the all-time high Centene hit early December and since then the price is -27.84% below that top. Since early February, when CNC stock price broke down the 40-weeks moving avarage line, it slid $-12.14 per share (-18.42%). Stocks below the 40w moving average line are usually not recommended for average traders.
Centene stock price history
Centene IPO was on December 13th, 2001 at $1.19 per share1. Since then, CNC stock surged a 4,416.80%, with a yearly average of 259.80%. If you had invested right after CNC's IPO a $1,000 in Centene stock in 2001, it would worth $44,168.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Centene stock historical price chart
CNC stock reached all-time highs on December with a price of $74.49.
Centene stock price target is $75.20Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 9 price targets for CNC stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-7-12||Morgan Stanley||Lowers Target||$75.00||$71.00||-5.3%|
|2019-4-24||SunTrust Banks||Lowers Target||n/a||$80.00||-|
|2019-4-24||Morgan Stanley||Lowers Target||$83.00||$75.00||-9.6%|
|2019-3-29||Credit Suisse Group||Lowers Target||$76.00||$63.00||-17.1%|
|2019-2-7||Jefferies Financial Group||Reiterates||n/a||$76.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Centene was in line with the estimates of the experts and posted an EPS of $0.69 per share. As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Centene annual sales climbed a super good 24.25% to $60,116.00 million USD from $48,382.00 marked in 2017. Instead, its income margin (compared to sales) remained steady to 1.50%, that is $900.00 million.
|2013||$10,860 M||-||$161 M1.5%||-|
|2014||$16,560 M||52.49%||$271 M1.6%||68.09%|
|2015||$22,760 M||37.44%||$355 M1.6%||31.00%|
|2016||$40,607 M||78.41%||$562 M1.4%||58.31%|
|2017||$48,382 M||19.15%||$828 M1.7%||47.33%|
|2018||$60,116 M||24.25%||$900 M1.5%||8.70%|
Quarterly financial resultsCentene reported $16,559.00 M in sales for 2018-Q4, a 2.33% up compared to previous quarter. Reported quarter income marked $241.00 M with a profit margin of 1.46%. Profit margin stepped up a 1.34% compared to previous quarter when profit margin was 0.12%. When comparing revenues to same quarter last year, Centene sales marked an exceptional gain and skyrocketed a 29.31%. Looking back to recent quarterly results, Centene posted 5 positive quarters in a row.
|2017-Q2||$11,950 M||-||$254 M2.1%||-|
|2017-Q3||$11,900 M||-0.42%||$205 M1.7%||-19.29%|
|2017-Q4||$12,806 M||7.61%||$230 M1.8%||12.20%|
|2018-Q1||$13,194 M||3.03%||$340 M2.6%||47.83%|
|2018-Q2||$14,181 M||7.48%||$300 M2.1%||-11.76%|
|2018-Q3||$16,182 M||14.11%||$19 M0.1%||-93.67%|
|2018-Q4||$16,559 M||2.33%||$241 M1.5%||1,168.42%|
|2019-Q1||$18,444 M||11.38%||$522 M2.8%||116.60%|
Centene ownershipWhen you are planning to invest in a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Centene, 2.40% of all outstanding shares are owned by its staff.
Bearish positions for CNC stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Centene:
|Market cap||$9.3 B||$78.5 B||$547.1 M||$38.4 B||$8.9 B|
|Total shares||173.6 M||257.2 M||22.2 M||135.0 M||62.6 M|
|Float shares||407.9 M||256.9 M||21.3 M||134.7 M||52.0 M|
|- Institutional holdings (%)||92.3%||91.4%||85.6%||96.4%||106.5%|
|- Insider holdings (%)||2.4%||0.2%||2.5%||0.2%||0.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Tuesday, July 16th, 2019|
|Day range||$53.48 - $54.16|
|Average true range||$1.47|
|50d mov avg||$54.37|
|100d mov avg||$54.97|
|200d mov avg||$60.20|
Centene performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We compared Centene against Anthem, Triple-S Management, Humana, Molina Healthcare and WellCare Health Plans in the following table:
|WCGWellCare Health P...||15.11%||9.85%||13.36%|
Centene competitorsWe selected a few stocks to conform a list of Centene competitors to watch if you are interested in investing in CNC:
- Anthem (ANTM)
- Triple-S Management (GTS)
- Humana (HUM)
- Molina Healthcare (MOH)
- WellCare Health Plans (WCG)
Latest Centene stock news
- Seeking AlphaCentene: A Growth Healthcare Stock At A Bargain ValueJuly 12, 2019
- Seeking AlphaCentene Undervalued; Patient Shareholders Will ProfitJuly 9, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Mosaic, Centene and American AirlinesJuly 2, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Centene, Boston Scientific and Hewlett Packard EnterpriseMay 28, 2019
- InvestorPlaceThursday’s Vital Data: Centene, Netflix and AppleMarch 28, 2019